Zoono Group Ltd traded at 0.07 this Wednesday February 4th, decreasing 0.002 or 2.74 percent since the previous trading session. Looking back, over the last four weeks, Zoono lost 1.43 percent. Over the last 12 months, its price rose by 173.08 percent. Looking ahead, we forecast Zoono Group Ltd to be priced at 0.07 by the end of this quarter and at 0.07 in one year, according to Trading Economics global macro models projections and analysts expectations.
Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries. The Company produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.